Global Home Diagnostics Market is expected to grow at a CAGR of 3.98% during the forecast period from 2018-2025
A new research report published by Fior Markets with the title Home Diagnostics Market by Test Type (Glucose Monitoring, Pregnancy Test, HIV Test Kits, Others), Form Type, Sample Type, Regions, and Global Forecast 2018-2025.
As per the report, the global home diagnostics market is expected to grow from USD 4.78 Billion in 2017 to USD 6.53 Billion by 2025, at a CAGR of 3.98% during the forecast period from 2018-2025. North America region led the global demand for the home diagnostics with a 39.79% share of market revenue in 2017. However Asia Pacific region is projected to progress at the highest CAGR of 6.02% over the forecast period.
DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/386013/request-sample
Major players in the global home diagnostics market are Abbott Laboratories, ACON Laboratories Inc., BTNX Inc., ARKRAY Inc., Assure Tech (Hangzhou) co. Ltd., Becton Dickinson & Company, Bionime Corporation, Roche Holding AG, Quidel Corporation, and True Diagnostics Inc, Bayer AG, Siemens AG, Abaxis Inc., Beckman Coulter Inc., Alere Inc., Trinity Biotech Plc, Danaher Corporation, and among others. There is rising environmental concern regarding improper disposal of self-diagnostic test kits. Thus to overcome this challenge manufacturers are progressively turning towards the sustainable biodegradable products. For instance an US start-up Lia in 2017, announced the launch of flushable pregnancy test that is made from sustainable, biodegradable materials. The modernized design is made from the same non-woven, natural plant fibres that make up most toilet paper. The testing kit weighs less than six squares of toilet paper.
Test type segment is divided into glucose monitoring devices, pregnancy test, HIV test kits, ovulation predictor test kits, cholesterol detection kits, drug of abuse test kits, and others. Drug abuse test kits is further segmented into marijuana, opiates, benzodiazepines, alcohol abuse and others. Due to the factors such as increasing worldwide prevalence of diabetes and the growing need for monitoring sugar levels among diabetes patients, the glucose monitoring devices segment emerged as the leader with USD 2.10 billion revenue in 2017. Due to growing prevalence of the cardiac disorders the cholesterol detection kits segment is anticipated to progress at a steady pace over the forecast period. Form type segment is categorized into cassette, strip, midstream, test panel, dip card, and others. Owing to its easy to use, simple and low cost properties, the cassette segment led the global home diagnostics segment with USD 1.40 billion revenue in 2017. Sample type is segmented into urine, blood, saliva and others. Due to its widespread use for detecting pregnancy, ovulation or drugs, the urine sample type segment led the global home diagnostics market with USD 1.85 billion revenue in 2017.
Although the factors such as Rising awareness about the importance of self-monitoring and self-diagnosis of diseases, Growing geriatric population around the world, as well as Increasing prevalence diabetes are driving the global home diagnostics market. The high cost of the self-diagnosis kits and stringent regulatory approval process are anticipated to hamper the market growth over the forecast period.
About the report:
The global Home Diagnostics market is analysed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on firstname.lastname@example.org or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
- CDN Newswire